Scandinavian Journal of Clinical and Laboratory Investigation · 2011 · 32 citations · 14 references
MedicineEndocrinologyNeurologyEndocrine OncologyNeuro-oncologyNeuroendocrinologyAdrenal EndocrinologyAdrenal HormonesAdrenal TumorsEndocrine Tumor DiagnosisEndocrine TumorsHormone-secreting TumorsAdrenal Tumor DiagnosisBiochemical CharacterizationHigh-sensitivity AssaysParaganglioma DetectionParaganglioma DiagnosisPheochromocytoma DetectionPheochromocytoma Diagnosis
BACKGROUND: The diagnosis of pheochromocytomas requires consideration among patients suffering from hypertension, unexplained spells, incidental adrenal masses, or a family history of pheochromocytoma. Accordingly, the diagnosis requires a biochemical test with high sensitivity and specificity. AIM: To compare plasma free metanephrines as measured by a commercial immunoassay and the 24-hour urinary excretion of catecholamines. METHOD: Plasma free metanephrines were measured in 185 patients suspected of pheochromocytoma. Concomitant measurements of urinary catecholamines were performed in 115 patients. Based on clinical findings, imaging and biochemistry 11 cases were found; 9 were diagnosed with pheochromocytoma, one patient with paraganglioma and one patient with ganglioneuroma. RESULTS: All patients with pheochromocytoma/paraganglioma had abnormally elevated concentrations of either plasma metanephrine or normetanephrine. The patient with ganglioneuroma had normal plasma metanephrine levels, corresponding to a sensitivity of 91%. In two patients where pheochromocytoma was excluded, plasma metanephrin or normetanephrine was above the reference level, corresponding to a specificity of 99%. Urinary catecholamines were determined in 10 of 11 patients with a positive diagnosis, and all 10 showed elevated levels of either urinary epinephrine or norepinephrine, including the patient with ganglioneuroma (equivalent to a sensitivity of 100%). Seven patients, in whom pheochromocytoma was excluded, had elevated urinary catecholamines (equivalent to a specificity of 94%). CONCLUSION: Measurement of plasma free metanephrines by immunoassay appears to be a useful diagnostic test in patients suspected of pheochromocytoma, with a high specificity as compared with urinary catecholamines. The latter may result in fewer false-positive findings, an outcome which may be particularly troublesome.
14
Biochemical Diagnosis of Pheochromocytoma
Jacques W.M. Lenders, Karel Pacák, McClellan M. Walther et al. · JAMA · 2002 · 1.1K citations
Medicine, Endocrinology, Oncology +16
Anna M. Sawka, Roman Jaeschke, Ravinder J. Singh et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 507 citations
Metabolic activity and clinical features of primary ganglioneuromas
Birgit Geoerger, Barbara Hero, D. Harms et al. · Cancer · 2001 · 343 citations · Full text
Plasma Metanephrines in the Diagnosis of Pheochromocytoma
Jacques W.M. Lenders · Annals of Internal Medicine · 1995 · 245 citations
Medicine, Cardiology, Endocrinology +15